"Unconscionable": Pfizer, Moderna to Rake in $93 Billion in 2022 COVID-19 Vaccine Sales
If you think big pharma companies are making a fortune on COVID-19 vaccine sales this year, just wait for 2022.
Pfizer and Moderna are projected to generate combined sales of $93.2 billion in 2022 nearly twice the amount they’re expected to rake in this year. Airfinity put total market sales for COVID-19 vaccines in 2022 at $124 billion, according to the Financial Times.
“The numbers are unprecedented,” Rasmus Beck Hansen, CEO of Airfinity, told the Financial Times.
Pfizer vaccine sales are predicted to reach $54.5 billion in 2022, and Moderna’s will hit $38.7 billion. The estimates blow the earlier figures—$23.6 billion for Pfizer and $20 billion for Moderna—out of the water.
Sales of the mRNA shots will continue to rise in 2022 due to boosters and countries stockpiling to ward off variants.
It's lucky they can predict the future and know there will be the need for millions more of the 'vaccine'. It's almost like they're running it.